Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment(148 visite) Perri F, Longo F, Della Vittoria Scarpati G, Pisconti S, Longo V, Addeo R, Carducci F, Buonerba C, Fulciniti F, Solla R
Clin Case Rep (ISSN: 2050-0904print, 2050-0904linking), 2017 Nov 24; 6(1): 56-62.
Tipo di articolo: Journal Article,
Impact factor: 0.54, Impact factor a 5 anni: 0
Url: Non disponibile.
Parole chiave: Cyclin D1, P16, Human Papillomavirus, Oropharyngeal Carcinoma,
*** IBB - CNR *** Medical Oncology DepartmentPOC SS AnnunziataTarantoItaly., Otolaryngology UnitNational Tumour Institute of Naples, G PascaleNaplesItaly., Department of Medical OncologyHospital S Giovanni di DioNaplesItaly., Otolaryngology UnitPOC SS AnnunziataTarantoItaly., Medical Oncology DepartmentUniversity Federico II of NaplesNaplesItaly., Pathology UnitClinica LuganeseLuganoSwitzerland., Institute of Biostructure and BioimagingNational Council of ResearchNaplesItaly., Department of Advanced Biomedical SciencesFederico II University School of MedicineNaplesItaly.,
Pretherapy assessment has a crucial role in the management of advanced oropharyngeal carcinoma. The case report represents an example of how translational research may help to optimize the therapeutic options and to choose a well-shaped therapy adapted to the tumor and the patient.